EE505 Cost-Effectiveness of Ofatumumab in Treatment of Relapsing Multiple Sclerosis in Turkey von Tatar, M., Yarcı, B., Akdemir, A.C., Ölmez, Ç, İğde, F., Tınaz, E., Turanlı, M.

Volltext

EE650 Cost Effectiveness of Siponimod for Secondary Progressive Multiple Sclerosis in Turkey von Tatar, M, Özbalas, T, Saraçoğlu, B, Ölmez, Ç, Yarci, B, Akdemir, AC, Yılmaz, C, Şen, S

Volltext

The cycle outcomes of GnRH agonist triggering with different leuprolide acetate doses in high responder patients von Pabuccu, R, Pabuccu, E.G, Caglar, G, Yilmaz, B, Yarci, A

Volltext

P.1.g.009 Effect of agmatine on cognition and hippocampal brain-derived neurotrophic factor expression in chronic unpredictable mild stress von Yazir, Y, Gümrü, S, Yarci, E, Cabadak, H, Aydin, B, Utkan, T, Aricioglu, F

Volltext